Explore
Trendline
Merck and Amgen Focus on Cholesterol Reduction to Combat Heart Disease
Merck and Amgen Focus on Cholesterol Reduction to Combat Heart Disease
Read More
Trendline
Agenus Advances BOT+BAL Immunotherapy with Phase 3 Trial and Strategic Collaborations
Agenus Advances BOT+BAL Immunotherapy with Phase 3 Trial and Strategic Collaborations
Read More
Trendline
Avenacy Launches Ready-to-Use Tranexamic Acid Injection in U.S. Market
Avenacy Launches Ready-to-Use Tranexamic Acid Injection in U.S. Market
Read More
Trendline
Energy Workforce Technology Council Reports Job Growth in Energy Services
Energy Workforce Technology Council Reports Job Growth in Energy Services
Read More
Trendline
Ivanhoe Electric to Acquire Tunnel Boring Machine for Santa Cruz Copper Project Development
Ivanhoe Electric to Acquire Tunnel Boring Machine for Santa Cruz Copper Project Development
Read More
Trendline
JCR Pharmaceuticals to Showcase Gene Therapy Innovations at ASGCT Meeting in Boston
JCR Pharmaceuticals to Showcase Gene Therapy Innovations at ASGCT Meeting in Boston
Read More
Trendline
Kopin Establishes U.S. OLED Microdisplay Manufacturing for Defense
Kopin Establishes U.S. OLED Microdisplay Manufacturing for Defense
Read More
Trendline
Georgia Tech Expands AI Manufacturing Testbed to Boost Industry Collaboration
Georgia Tech Expands AI Manufacturing Testbed to Boost Industry Collaboration
Read More
Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement
Read More
Trendline
Eli Lilly Invests $4.5 Billion in Indiana for Genetic Medicine Manufacturing Expansion
Eli Lilly Invests $4.5 Billion in Indiana for Genetic Medicine Manufacturing Expansion
Read More
Trendline
CleanSpace Unveils CleanSource, a U.S.-Manufactured Digital Marketplace for Cleanroom Products
CleanSpace Unveils CleanSource, a U.S.-Manufactured Digital Marketplace for Cleanroom Products
Read More
Trendline
Vistagen Completes Phase 3 Study for Fasedienol in Social Anxiety Disorder
Vistagen Completes Phase 3 Study for Fasedienol in Social Anxiety Disorder
Read More